Suite 4000
150 John F. Kennedy Parkway
Short Hills, NJ 07078-2702
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 27, 2025, with respect to the consolidated financial statements of PDS Biotechnology Corporation, incorporated herein by
reference.